Is the Complement Protein C1q a Pro- or Anti-tumorigenic Factor? Bioinformatics Analysis Involving Human Carcinomas
C1q is the first subcomponent of the classical pathway of the complement system and belongs to the C1q/Tumor Necrosis Factor superfamily. C1q can perform a diverse range of immune and non-immune functions in a complement-dependent as well as -independent manner. Being a pattern recognition molecule...
Main Authors: | Alessandro Mangogna, Chiara Agostinis, Deborah Bonazza, Beatrice Belmonte, Paola Zacchi, Gabriella Zito, Andrea Romano, Fabrizio Zanconati, Giuseppe Ricci, Uday Kishore, Roberta Bulla |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.00865/full |
Similar Items
-
Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target
by: Chiara Agostinis, et al.
Published: (2021-01-01) -
Prognostic Implications of the Complement Protein C1q in Gliomas
by: Alessandro Mangogna, et al.
Published: (2019-10-01) -
COVID-19, Pre-Eclampsia, and Complement System
by: Chiara Agostinis, et al.
Published: (2021-11-01) -
Anti-Spike Antibodies Present in the Milk of SARS-CoV-2 Vaccinated Mothers Are Complement-Activating
by: Chiara Agostinis, et al.
Published: (2023-02-01) -
The Inflammatory Feed-Forward Loop Triggered by the Complement Component C3 as a Potential Target in Endometriosis
by: Chiara Agostinis, et al.
Published: (2021-08-01)